GB9120306D0
(en)
|
1991-09-24 |
1991-11-06 |
Graham Herbert K |
Method and compositions for the treatment of cerebral palsy
|
EP1563843B1
(de)
*
|
1993-12-28 |
2013-08-07 |
Allergan, Inc. |
Botulinustoxin zur Behandlung von Muskelkrankheiten
|
US6974578B1
(en)
*
|
1993-12-28 |
2005-12-13 |
Allergan, Inc. |
Method for treating secretions and glands using botulinum toxin
|
US20040126396A1
(en)
*
|
1993-12-28 |
2004-07-01 |
Allergan, Inc. |
Botulinum toxin treatment for strabismus
|
US8187612B2
(en)
|
1993-12-28 |
2012-05-29 |
Allergan, Inc. |
Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle
|
US8557256B2
(en)
|
1993-12-28 |
2013-10-15 |
Allergan, Inc. |
Treatment for cervical dystonia with the neurotoxic component of a botulinum toxin
|
US5721215A
(en)
*
|
1996-03-20 |
1998-02-24 |
Allergan |
Injectable therapy for control of muscle spasms and pain related to muscle spasms
|
US6063768A
(en)
*
|
1997-09-04 |
2000-05-16 |
First; Eric R. |
Application of botulinum toxin to the management of neurogenic inflammatory disorders
|
EP1053014A4
(de)
|
1998-01-26 |
2004-11-10 |
Univ Massachusetts |
BIOLOGISCH AKTIVES HÄMAGGLUTININ VOM TYP A i(STRIDIUM BOTULINUM) UNDVERFAHREN ZU SEINER VERWENDUNG
|
US7537773B1
(en)
*
|
1998-08-25 |
2009-05-26 |
Botulinum Toxin Research Associates, Inc. |
Chemodenervating pharmaceutical as anti-inflammatory agent
|
US6139545A
(en)
*
|
1998-09-09 |
2000-10-31 |
Vidaderm |
Systems and methods for ablating discrete motor nerve regions
|
TW574036B
(en)
|
1998-09-11 |
2004-02-01 |
Elan Pharm Inc |
Stable liquid compositions of botulinum toxin
|
AUPP627498A0
(en)
*
|
1998-10-02 |
1998-10-22 |
University Of Queensland, The |
Novel peptides - i
|
DE60041752D1
(de)
*
|
1999-04-16 |
2009-04-23 |
Marvin Schwartz |
Verfahren zur verminderung des haarausfalls und förderung des haarwiederwachstums
|
DE19925739A1
(de)
|
1999-06-07 |
2000-12-21 |
Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh |
Therapeutikum mit einem Botulinum-Neurotoxin
|
US6767544B2
(en)
*
|
2002-04-01 |
2004-07-27 |
Allergan, Inc. |
Methods for treating cardiovascular diseases with botulinum toxin
|
US6113915A
(en)
*
|
1999-10-12 |
2000-09-05 |
Allergan Sales, Inc. |
Methods for treating pain
|
US6265379B1
(en)
*
|
1999-10-13 |
2001-07-24 |
Allergan Sales, Inc. |
Method for treating otic disorders
|
US7838008B2
(en)
*
|
1999-12-07 |
2010-11-23 |
Allergan, Inc. |
Methods for treating diverse cancers
|
US7838007B2
(en)
|
1999-12-07 |
2010-11-23 |
Allergan, Inc. |
Methods for treating mammary gland disorders
|
US6429189B1
(en)
*
|
1999-12-10 |
2002-08-06 |
Botulinum Toxin Research Associates, Inc. |
Cytotoxin (non-neurotoxin) for the treatment of human headache disorders and inflammatory diseases
|
US7138127B1
(en)
*
|
2000-01-19 |
2006-11-21 |
Allergan, Inc. |
Clostridial toxin derivatives and methods for treating pain
|
US6500436B2
(en)
|
2000-01-19 |
2002-12-31 |
Allergan, Inc. |
Clostridial toxin derivatives and methods for treating pain
|
US6641820B1
(en)
|
2000-01-19 |
2003-11-04 |
Allergan, Inc. |
Clostridial toxin derivatives and methods to treat pain
|
US20060269575A1
(en)
*
|
2000-02-08 |
2006-11-30 |
Allergan, Inc. |
Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
|
DK1253932T3
(da)
*
|
2000-02-08 |
2005-06-27 |
Allergan Inc |
Lægemidler med botulinustoxin
|
US8632785B2
(en)
*
|
2000-02-08 |
2014-01-21 |
Allergan, Inc. |
Clostridial toxin pharmaceutical composition containing a gelatin fragment
|
US7780967B2
(en)
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
US20030118598A1
(en)
*
|
2000-02-08 |
2003-06-26 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
US6821520B2
(en)
*
|
2000-02-15 |
2004-11-23 |
Allergan, Inc. |
Clostridial toxin therapy for Hashimoto's thyroiditis
|
US6753315B2
(en)
*
|
2000-02-24 |
2004-06-22 |
Brown University Research Foundation |
α-bungarotoxin molecules and uses thereof
|
US6464986B1
(en)
*
|
2000-04-14 |
2002-10-15 |
Allegan Sales, Inc. |
Method for treating pain by peripheral administration of a neurotoxin
|
US6299893B1
(en)
*
|
2000-04-17 |
2001-10-09 |
Marvin Schwartz |
Method to reduce hair loss and stimulate hair regrowth
|
US6565870B1
(en)
|
2000-04-28 |
2003-05-20 |
Allergan, Inc. |
Methods for treating bone tumors
|
US20040033241A1
(en)
*
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
US20040170665A1
(en)
*
|
2000-06-02 |
2004-09-02 |
Allergan, Inc. |
Intravitreal botulinum toxin implant
|
AU2001270219A1
(en)
*
|
2000-06-28 |
2002-01-08 |
Ira Sanders |
Methods for using tetanus toxin for benificial purposes in animals (mammals)
|
US7691983B2
(en)
*
|
2000-07-21 |
2010-04-06 |
Allergan, Inc. |
Chimera botulinum toxin type E
|
US6903187B1
(en)
*
|
2000-07-21 |
2005-06-07 |
Allergan, Inc. |
Leucine-based motif and clostridial neurotoxins
|
US20040219619A1
(en)
*
|
2000-07-21 |
2004-11-04 |
Ester Fernandez-Salas |
Methods of identifying compounds that alter toxin persistence and/or protease activity
|
US7491799B2
(en)
*
|
2000-07-21 |
2009-02-17 |
Allergan, Inc. |
Modified botulinum neurotoxins
|
US20020127247A1
(en)
|
2000-11-17 |
2002-09-12 |
Allergen Sales, Inc. |
Modified clostridial neurotoxins with altered biological persistence
|
US7223577B2
(en)
*
|
2000-11-17 |
2007-05-29 |
Allergan, Inc. |
Post-translational modifications and Clostridial neurotoxins
|
US20020086036A1
(en)
|
2000-12-05 |
2002-07-04 |
Allergan Sales, Inc. |
Methods for treating hyperhidrosis
|
US7255865B2
(en)
|
2000-12-05 |
2007-08-14 |
Allergan, Inc. |
Methods of administering botulinum toxin
|
US20020192239A1
(en)
*
|
2001-01-09 |
2002-12-19 |
Borodic Gary E. |
Use of botulinum toxin for the treatment of chronic facial pain
|
JP4707254B2
(ja)
*
|
2001-04-24 |
2011-06-22 |
クミアイ化学工業株式会社 |
粒状組成物及びその製造方法
|
US6623742B2
(en)
|
2001-09-17 |
2003-09-23 |
Allergan, Inc. |
Methods for treating fibromyalgia
|
US7255866B2
(en)
|
2001-09-17 |
2007-08-14 |
Allergan, Inc. |
Botulinum toxin therapy for fibromyalgia
|
HUP0402268A2
(hu)
*
|
2001-11-15 |
2005-02-28 |
Micro Algae Corp. |
3,4-propinoperhidropurinokat tartalmazó gyógyászati kompozíciók és alkalmazásuk ingerületátvitel gátlására
|
US7022329B2
(en)
*
|
2002-02-25 |
2006-04-04 |
Allergan, Inc. |
Method for treating neurogenic inflammation pain with botulinum toxin and substance P components
|
WO2003073994A2
(en)
*
|
2002-03-01 |
2003-09-12 |
Elan Pharmaceuticals, Inc. |
Methods of treating nerve entrapment syndromes
|
US7140371B2
(en)
*
|
2002-03-14 |
2006-11-28 |
Allergan, Inc. |
Surface topography method for determining effects of a botulinum toxin upon a muscle and for comparing botulinum toxins
|
US6688311B2
(en)
|
2002-03-14 |
2004-02-10 |
Allergan, Inc. |
Method for determining effect of a clostridial toxin upon a muscle
|
US6921538B2
(en)
*
|
2002-05-10 |
2005-07-26 |
Allergan, Inc. |
Therapeutic treatments for neuropsychiatric disorders
|
US7691394B2
(en)
*
|
2002-05-28 |
2010-04-06 |
Botulinum Toxin Research Associates, Inc. |
High-potency botulinum toxin formulations
|
WO2004035011A2
(en)
*
|
2002-10-15 |
2004-04-29 |
Allergan, Inc. |
Botulinum toxin dental therapies and procedures
|
US7238357B2
(en)
*
|
2002-11-05 |
2007-07-03 |
Allergan, Inc. |
Methods for treating ulcers and gastroesophageal reflux disease
|
US20040086532A1
(en)
*
|
2002-11-05 |
2004-05-06 |
Allergan, Inc., |
Botulinum toxin formulations for oral administration
|
US7758872B1
(en)
|
2003-02-07 |
2010-07-20 |
Eric Finzi |
Method of treating depression
|
EP1599213A4
(de)
*
|
2003-02-24 |
2009-07-15 |
Ira Sanders |
Zellmembran-translokation von regulierten snare- inhibitoren, zusammensetzungen dafür und verfahren zur behandlung von erkrankungen
|
US8071550B2
(en)
*
|
2003-03-03 |
2011-12-06 |
Allergan, Inc. |
Methods for treating uterine disorders
|
EP1599220B1
(de)
*
|
2003-03-06 |
2013-07-17 |
Botulinum Toxin Research Associates, Inc. |
Auswahl von patienten mit erhöhtem ansprechen auf botulinustoxin
|
US8691769B2
(en)
*
|
2003-03-06 |
2014-04-08 |
Botulinum Toxin Research Associates, Inc. |
Treatment of sinusitis related chronic facial pain and headache with botulinum toxin injections
|
US20040247623A1
(en)
*
|
2003-03-24 |
2004-12-09 |
Roger Cady |
Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin
|
NZ542864A
(en)
*
|
2003-04-16 |
2008-04-30 |
Allergan Inc |
Controlled volume injection/aspiration device
|
US7422753B2
(en)
*
|
2003-04-25 |
2008-09-09 |
Allergan, Inc. |
Methods for treating trichotillomania
|
US7396535B2
(en)
*
|
2003-04-25 |
2008-07-08 |
Ackerman Alan H |
Therapy for obsessive compulsive head banging
|
US7393538B2
(en)
*
|
2003-04-25 |
2008-07-01 |
Ackerman Alan H |
Clostridial toxin treatment for dermatillomania
|
US7393537B2
(en)
*
|
2003-04-25 |
2008-07-01 |
Allergan, Inc. |
Botulinum toxin for treatment of obsessive compulsive finger biting disorder
|
US7390496B2
(en)
*
|
2003-04-25 |
2008-06-24 |
Allergan, Inc. |
Therapeutic treatments for repetitive hand washing
|
US6838434B2
(en)
*
|
2003-05-02 |
2005-01-04 |
Allergan, Inc. |
Methods for treating sinus headache
|
US7220422B2
(en)
*
|
2003-05-20 |
2007-05-22 |
Allergan, Inc. |
Methods and compositions for treating eye disorders
|
US20040253274A1
(en)
*
|
2003-06-11 |
2004-12-16 |
Allergan, Inc. |
Use of a clostridial toxin to reduce appetite
|
US20050013850A1
(en)
*
|
2003-07-15 |
2005-01-20 |
Caers Jan K. |
Device to assist hyperhydrosis therapy
|
US8617572B2
(en)
|
2003-10-29 |
2013-12-31 |
Allergan, Inc. |
Botulinum toxin treatments of depression
|
US8734810B2
(en)
|
2003-10-29 |
2014-05-27 |
Allergan, Inc. |
Botulinum toxin treatments of neurological and neuropsychiatric disorders
|
US7172764B2
(en)
*
|
2003-11-17 |
2007-02-06 |
Allergan, Inc. |
Rescue agents for treating botulinum toxin intoxications
|
US8871224B2
(en)
|
2003-12-09 |
2014-10-28 |
Allergan, Inc. |
Botulinum toxin therapy for skin disorders
|
US8048423B2
(en)
*
|
2003-12-09 |
2011-11-01 |
Allergan, Inc. |
Botulinum toxin therapy for skin disorders
|
US20050129677A1
(en)
*
|
2003-12-10 |
2005-06-16 |
Shengwen Li |
Lipid rafts and clostridial toxins
|
US20050148935A1
(en)
*
|
2003-12-29 |
2005-07-07 |
Rozalina Dimitrova |
Botulinum toxin injection guide
|
US7270287B2
(en)
*
|
2004-01-06 |
2007-09-18 |
Allergan, Inc. |
Botulinum toxin treatment for kinesia
|
US6974579B2
(en)
*
|
2004-01-08 |
2005-12-13 |
Allergan, Inc. |
Methods for treating vascular disorders
|
US9078892B2
(en)
|
2004-02-26 |
2015-07-14 |
Allergan, Inc. |
Methods for treating pain and for treating a medication overuse disorder
|
US20050191321A1
(en)
*
|
2004-02-26 |
2005-09-01 |
Allergan, Inc. |
Methods for treating headache
|
US20100266638A1
(en)
|
2004-02-26 |
2010-10-21 |
Allergan, Inc. |
Headache treatment method
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
JP2007527431A
(ja)
*
|
2004-03-03 |
2007-09-27 |
ルバンス セラピュティックス |
局所的診断及び治療用の輸送のための組成物及び方法
|
US20050220821A1
(en)
*
|
2004-03-31 |
2005-10-06 |
Allergan, Inc. |
Pressure sore treatment
|
US20050220734A1
(en)
*
|
2004-04-02 |
2005-10-06 |
Allergan, Inc. |
Therapy for melanin related afflictions
|
AU2005244096B2
(en)
*
|
2004-05-07 |
2011-03-17 |
Algenis Spa |
Transdermal administration of phycotoxins
|
CA2607589A1
(en)
*
|
2004-05-07 |
2005-11-24 |
Phytotox Limited |
Methods of treating wounds with gonyautoxins
|
US6991789B2
(en)
*
|
2004-06-29 |
2006-01-31 |
Allergas, Inc. |
Methods of modulating intracellular degradation rates of toxins
|
US7922983B2
(en)
*
|
2005-07-28 |
2011-04-12 |
Kimberly-Clark Worldwide, Inc. |
Sterilization wrap with additional strength sheet
|
US7811584B2
(en)
|
2004-06-30 |
2010-10-12 |
Allergan, Inc. |
Multivalent clostridial toxins
|
EP3153159A1
(de)
|
2004-07-09 |
2017-04-12 |
Robert Sabin |
Zusammensetzungen mit einer kupferverbindung zur behandlung von erkrankungen bei säugetieren
|
US20070258900A1
(en)
*
|
2004-07-20 |
2007-11-08 |
Joseph Francis |
Blood Flow Assessment of Clostridial Toxin Applications
|
US8173797B2
(en)
*
|
2004-07-21 |
2012-05-08 |
Cornell Research Foundation, Inc. |
Therapeutic compounds derived from spider venom and their method of use
|
US20060024794A1
(en)
*
|
2004-07-30 |
2006-02-02 |
Shengwen Li |
Novel methods for production of di-chain botulinum toxin
|
US20060024331A1
(en)
*
|
2004-08-02 |
2006-02-02 |
Ester Fernandez-Salas |
Toxin compounds with enhanced membrane translocation characteristics
|
US7429386B2
(en)
*
|
2004-09-03 |
2008-09-30 |
Allergan, Inc. |
Stretch mark treatment
|
US7179474B2
(en)
*
|
2004-09-03 |
2007-02-20 |
Allergan, Inc. |
Methods for treating a buttock deformity
|
US20060073208A1
(en)
|
2004-10-01 |
2006-04-06 |
Allergan, Inc. |
Cosmetic neurotoxin compositions and methods
|
US7897147B2
(en)
*
|
2004-10-20 |
2011-03-01 |
Allergan, Inc. |
Treatment of premenstrual disorders
|
AU2012241076B2
(en)
*
|
2005-02-01 |
2015-05-14 |
Allergan, Inc. |
Targeted delivery of Botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions
|
US7655244B2
(en)
|
2005-02-01 |
2010-02-02 |
Allergan, Inc. |
Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions
|
US7749515B2
(en)
|
2005-02-01 |
2010-07-06 |
Allergan, Inc. |
Targeted delivery of botulinum toxin to the sphenopalatine ganglion
|
CA2599017C
(en)
|
2005-03-03 |
2014-08-12 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
ES2509872T3
(es)
|
2005-03-03 |
2014-10-20 |
Allergan, Inc. |
Procedimientos para obtener una toxina clostrídica
|
US7731411B2
(en)
*
|
2005-04-04 |
2010-06-08 |
Schlumberger Technology Corporation |
Circulating fluid system for powder fluidization and method of performing same
|
WO2006122123A2
(en)
*
|
2005-05-09 |
2006-11-16 |
Levin Bruce H |
Methods of alleviating disorders and their associated pain
|
US7419675B2
(en)
*
|
2005-05-26 |
2008-09-02 |
Allergan, Inc. |
Method for treating peritoneal adhesions
|
US8105611B2
(en)
|
2005-06-17 |
2012-01-31 |
Allergan, Inc. |
Treatment of autoimmune disorder with a neurotoxin
|
US7910116B2
(en)
*
|
2005-08-24 |
2011-03-22 |
Allergan, Inc. |
Use of a botulinum toxin to improve gastric emptying and/or to treat GERD
|
DE102005058639A1
(de)
*
|
2005-12-07 |
2007-07-26 |
Armin Maurer |
Behandlung von Trichodynie und anschwellender Arteria temporalis superficialis
|
US7824694B2
(en)
*
|
2006-01-12 |
2010-11-02 |
Allergan, Inc. |
Methods for enhancing therapeutic effects of a neurotoxin
|
US20070178121A1
(en)
*
|
2006-01-27 |
2007-08-02 |
Allergan, Inc. |
Methods for enhancing skin treatments
|
US7794386B2
(en)
|
2006-03-15 |
2010-09-14 |
Allergan, Inc. |
Methods for facilitating weight loss
|
US20080021437A1
(en)
*
|
2006-04-27 |
2008-01-24 |
Boyd James P |
Enhancement of the efficacy of a clenching reduction device by augmenting with botulinum toxin type A
|
US7811586B2
(en)
*
|
2006-05-02 |
2010-10-12 |
Allergan, Inc. |
Methods for alleviating testicular pain
|
CN101074935B
(zh)
*
|
2006-05-19 |
2011-03-23 |
清华大学 |
探测器阵列及设备
|
US9061025B2
(en)
*
|
2006-08-31 |
2015-06-23 |
Allergan, Inc. |
Methods for selecting headache patients responsive to botulinum toxin therapy
|
US20080092910A1
(en)
*
|
2006-10-18 |
2008-04-24 |
Allergan, Inc. |
Apparatus and method for treating obesity using neurotoxins in conjunction with bariatric procedures
|
US20080113051A1
(en)
*
|
2006-11-13 |
2008-05-15 |
Allergan, Inc. |
Methods for alleviating tattoo pain
|
EP2117584B1
(de)
|
2007-02-15 |
2013-10-09 |
Allergan, Inc. |
Verwendung von botulinumtoxin und enzymen zur behandlung von blasenleiden
|
CN101903035A
(zh)
*
|
2007-10-23 |
2010-12-01 |
阿勒根公司 |
使用经修饰的梭菌毒素治疗慢性神经源性炎症的方法
|
US8470337B2
(en)
*
|
2008-03-13 |
2013-06-25 |
Allergan, Inc. |
Therapeutic treatments using botulinum neurotoxin
|
US8617571B2
(en)
|
2008-04-03 |
2013-12-31 |
Allergan, Inc. |
Suture line administration technique using botulinum toxin
|
ES2356883B1
(es)
*
|
2008-07-24 |
2012-02-22 |
Bcn Peptides, S.A. |
Composición para el tratamiento del dolor y/o la inflamación.
|
US20100028385A1
(en)
*
|
2008-08-04 |
2010-02-04 |
Allergan, Inc. |
Treatment of excess cerumen secretion
|
US8512715B2
(en)
|
2008-08-14 |
2013-08-20 |
The Cleveland Clinic Foundation |
Apparatus and method for treating a neuromuscular defect
|
US9204925B2
(en)
|
2008-08-14 |
2015-12-08 |
The Cleveland Clinic Foundation |
Apparatus and method for treating a neuromuscular defect
|
WO2010096134A1
(en)
|
2008-12-04 |
2010-08-26 |
Botulinum Toxin Research Associates, Inc. |
Extended length botulinum toxin formulation for human or mammalian use
|
CA2774951C
(en)
|
2009-09-24 |
2014-12-16 |
Allergan, Inc. |
Method of treating osteoporosis with a neurotoxin
|
US8940308B2
(en)
|
2010-03-30 |
2015-01-27 |
Allergan, Inc. |
Methods for treating depression
|
EP2627350A1
(de)
|
2010-10-14 |
2013-08-21 |
Allergan, Inc. |
Gezielte abgabe von gezielten exozytosemodulatoren an das ganglion sphenopalatinum zur behandlung von kopfschmerzen
|
US20120195878A1
(en)
|
2011-01-28 |
2012-08-02 |
Allergan, Inc. |
Protocol for the administration of botulinum toxins
|
US10111938B2
(en)
|
2011-03-30 |
2018-10-30 |
Allergan, Inc. |
Injection paradigm for administration of botulinum toxins
|
US8697090B2
(en)
|
2011-05-05 |
2014-04-15 |
Allergan, Inc. |
Method of treating persistent genital arousal disorder with a neurotoxin
|
US9764009B2
(en)
|
2011-06-13 |
2017-09-19 |
Allergan, Inc. |
Treatment of psychological trauma
|
US8992941B2
(en)
|
2011-07-08 |
2015-03-31 |
Allergan, Inc. |
Method for treatment of esophageal spasm
|
CA2841139C
(en)
|
2011-07-08 |
2017-01-17 |
Allergan, Inc. |
Method for treatment of autonomic nervous system disorders
|
RU2578475C2
(ru)
|
2011-07-14 |
2016-03-27 |
Аллерган, Инк. |
Способы лечения недержания, связанного с половой активностью
|
KR20140082956A
(ko)
|
2011-07-20 |
2014-07-03 |
알러간, 인코포레이티드 |
지방 침착물의 치료방법에 이용하기 위한 보툴리눔 독소
|
US8491917B1
(en)
|
2012-03-12 |
2013-07-23 |
William J. Bender |
Treatment of migraine headache with diffusion of toxin in non-muscle related areas of the head
|
US8722060B2
(en)
*
|
2012-05-23 |
2014-05-13 |
William J. Binder |
Method of treating vertigo
|
MX358613B
(es)
|
2012-03-12 |
2018-08-27 |
J Binder William |
Tratamiento de dolor de cabeza por migraña con neurotoxina presinaptica.
|
ES2424294B1
(es)
|
2012-03-22 |
2014-07-21 |
Lipotec, S.A. |
Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas
|
US9393291B2
(en)
|
2012-04-12 |
2016-07-19 |
Botulinum Toxin Research Associates, Inc. |
Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory beds
|
EP2649985A1
(de)
|
2012-04-13 |
2013-10-16 |
Lipotec, S.A. |
Verbindungen zur Hemmung neuronaler Exozytose (III)
|
BR112014025396B1
(pt)
|
2012-04-13 |
2020-03-17 |
Lubrizol Advanced Materials, Inc. |
Composto, composição cosmética ou farmacêutica, e, uso de um composto
|
EP2649984A1
(de)
|
2012-04-13 |
2013-10-16 |
Lipotec, S.A. |
Verbindungen zur Hemmung neuronaler Exozytose
|
EP2649983A1
(de)
|
2012-04-13 |
2013-10-16 |
Lipotec, S.A. |
Verbindungen zur Hemmung neuronaler Exozytose (II)
|
HUE053147T2
(hu)
|
2012-05-30 |
2021-06-28 |
Harvard College |
Módosított botulinum neurotoxin
|
US20140120077A1
(en)
|
2012-10-28 |
2014-05-01 |
Revance Therapeutics, Inc. |
Compositions and Methods for Safe Treatment of Rhinitis
|
WO2014078724A1
(en)
|
2012-11-16 |
2014-05-22 |
Finzi Eric |
Treatment of post-traumatic stress disorder using botulinum toxin a
|
EP2976060B1
(de)
|
2013-03-22 |
2016-10-26 |
Lipotec, S.A. |
Exopolysaccharide zur behandlung und/oder zum schutz der haut, schleimhäute und/oder nägel
|
US10149893B2
(en)
|
2013-09-24 |
2018-12-11 |
Allergan, Inc. |
Methods for modifying progression of osteoarthritis
|
US9480731B2
(en)
|
2013-12-12 |
2016-11-01 |
Medy-Tox, Inc. |
Long lasting effect of new botulinum toxin formulations
|
US9216210B2
(en)
|
2013-12-23 |
2015-12-22 |
Dublin City University |
Multiprotease therapeutics for chronic pain
|
US9901627B2
(en)
|
2014-07-18 |
2018-02-27 |
Revance Therapeutics, Inc. |
Topical ocular preparation of botulinum toxin for use in ocular surface disease
|
US11484580B2
(en)
|
2014-07-18 |
2022-11-01 |
Revance Therapeutics, Inc. |
Topical ocular preparation of botulinum toxin for use in ocular surface disease
|
HUE057258T2
(hu)
|
2015-03-26 |
2022-05-28 |
Harvard College |
Szerkesztett Botulinum neurotoxin
|
SG10201912099TA
(en)
|
2016-06-08 |
2020-02-27 |
Childrens Medical Center |
Engineered botulinum neurotoxins
|
AU2017292922B9
(en)
|
2016-07-08 |
2022-05-12 |
Children's Medical Center Corporation |
A novel botulinum neurotoxin and its derivatives
|
CN110072880A
(zh)
|
2016-08-24 |
2019-07-30 |
哈佛大学校长及研究员协会 |
工程化肉毒杆菌神经毒素
|
WO2018038301A1
(en)
|
2016-08-26 |
2018-03-01 |
Hugel Inc. |
Stabilized liquid formulation of botulinum toxin and preparation method thereof
|
JP2019526611A
(ja)
|
2016-09-13 |
2019-09-19 |
アラーガン、インコーポレイテッドAllergan,Incorporated |
非タンパク質クロストリジウム毒素組成物
|
CN112105379A
(zh)
|
2017-09-29 |
2020-12-18 |
儿童医学中心公司 |
神经毒素样毒素及其用途
|
EP3470054B1
(de)
|
2017-10-11 |
2023-09-20 |
Hugel Inc. |
Mikrostrukturformulierungstechniken für botulinumtoxin
|
US10792400B2
(en)
|
2017-10-12 |
2020-10-06 |
Hugel Inc. |
Microstructure formulation techniques for botulinum toxin
|
US10525111B2
(en)
|
2017-10-12 |
2020-01-07 |
Hugel, Inc. |
Microstructure formulation techniques for botulinum toxin
|
LT3660509T
(lt)
|
2018-11-29 |
2022-05-10 |
Hugel Inc. |
Ląstelių panaudojimu paremtas būdas botulino toksino aktyvumui nustatyti
|
US11752201B2
(en)
|
2019-01-07 |
2023-09-12 |
Babak Azizzadeh |
Treatment of stress disorders, including post-traumatic stress disorder, using acetylcholine release inhibiting neurotoxic proteins to reduce stress levels
|
AU2020340428A1
(en)
|
2019-08-30 |
2022-03-03 |
AEON Biopharma, Inc. |
Neurotoxin compositions for use in treating headache
|
TW202136518A
(zh)
|
2019-12-20 |
2021-10-01 |
瑞士商葛德瑪控股公司 |
生產肉毒桿菌毒素的方法
|